Effectiveness of pazopanib and SBRT in metastatic renal cell carcinoma

被引：0
|
作者：
Cihan, Yasemin Benderli [1 ]
机构：
[1] Kayseri Educ & Res Hosp, Dept Radiat Oncol, Ataturk Blvd,Hastane St 78, TR-38010 Kayseri, Turkey
来源：
WORLD JOURNAL OF UROLOGY | 2018年 / 36卷 / 11期
关键词：
BODY RADIATION-THERAPY;
D O I：
10.1007/s00345-018-2323-6
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1797 / 1798
页数：2
相关论文
共 50 条
  • [31] Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Editorial Comment
    Marshall, Fray F.
    JOURNAL OF UROLOGY, 2010, 184 (04): : 1303 - 1303
  • [32] Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib
    Fiala, Ondrej
    Ostasov, Pavel
    Rozsypalova, Aneta
    Hora, Milan
    Sorejs, Ondrej
    Sustr, Jan
    Bendova, Barbora
    Travnicek, Ivan
    Filipovsky, Jan
    Finek, Jindrich
    Buchler, Tomas
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4077 - 4086
  • [33] Liver toxicity in patients with metastatic renal cell carcinoma treated with pazopanib therapy
    Lim, L.
    Mathias, J.
    Lampron, M.
    Fehr, M.
    Gruenwald, V.
    Khan, M.
    Crabb, S.
    Choueiri, T.
    Powles, T.
    Rini, B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S660 - S660
  • [34] One-year survivor of metastatic renal cell carcinoma treated with Pazopanib
    Fam, Xeng Inn
    Singam, Praveen
    Goh, Eng Hong
    Jasman, Hafidzul
    Hing, Erica Yee
    Ahmed, Nurzarina
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 : 56 - 56
  • [35] The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscape
    Goebell, Peter J.
    Doehn, Christian
    Gruellich, Carsten
    Gruenwald, Viktor
    Steiner, Thomas
    Ehness, Rainer
    Welslau, Manfred
    FUTURE ONCOLOGY, 2017, 13 (17) : 1463 - 1471
  • [36] Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma
    Bukhari, Nedal
    Winquist, Eric
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (11): : E449 - E450
  • [37] LIVER TOXICITY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH PAZOPANIB THERAPY
    Lim, F. L.
    Shamash, J.
    Wilson, P.
    Powles, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 290 - 290
  • [38] A Case of Cardiac Tamponade in a Patient with Metastatic Renal Cell Carcinoma on Pazopanib Treatment
    Sarathy, Vinu
    Jayappa, Sriniivas Belagutty
    Waran, Thianesh
    Naik, Radheshyam
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2020, 2020
  • [39] Cost-effectiveness of sunitinib or pazopanib for metastatic renal cell carcinoma in Brazil: A public health system perspective.
    Sasse, Andre Deeke
    Carvalho, Adriana Camargo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [40] Real world effectiveness and safety of pazopanib and everolimus in metastatic renal cell carcinoma: first interim analysis of the PAZOREAL study
    Bedke, J.
    Welslau, M.
    Boegemann, M.
    Schostak, M.
    Hering-Schubert, C.
    Petzoldt, A.
    Wolf, T.
    Schleicher, J.
    Doehn, C.
    Gruellich, C.
    Gruenwald, V.
    Steiner, T.
    Ehness, R.
    Goebell, P. J.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 97 - +
12345